Tag: R&D
Budget 2026 unveils Rs 10,000 Crore ‘Biopharma Shakti’ scheme to fight...
Finance Minister Nirmala Sitharaman announces a five-year push to boost biologics research, manufacturing and innovation
Merck Healthcare R&D India unveils next-gen office in Bangalore to power...
Championing collaboration, India’s technological advances, and scientific excellence for future-ready R&D in Merck Healthcare
UK–US pharma policies and US manufacturing shape global investment strategies, says...
Ministers have already cited multi-billion-pound commitments from Moderna, Bristol Myers Squibb, and BioNTech as evidence that tariff certainty and pricing reforms are strengthening confidence in the UK as an R&D and manufacturing base.
Manthan 2026 concludes successfully, advancing dialogue on India’s clinical research &...
Senior leaders, policymakers, and experts discuss innovation, collaboration, and the future of life sciences R&D in India
Syngene International extends long-term research collaboration with Bristol Myers Squibb until...
The expansion of this collaboration marks the next phase of growth, reinforcing Syngene’s position as a strategic partner delivering integrated, end-to-end scientific and manufacturing solutions
Minister Sridhar Babu inaugurates India’s first logical single-use scale-up facility –...
Supporting this infrastructure, 1 Bio houses 150,000 sq. ft. of plug-and-play R&D labs, configurable innovation suites, shared analytical spaces equipped with advanced analytical systems, and dedicated bioprocess training labs
Elsevier launches LeapSpace: An AI-Assisted workspace to accelerate research and discovery
New integrated workspace will combine the broadest collection of trusted scientific content with responsible AI to help researchers move from curiosity to discovery faster
BioVoice eMagazine November 2025 | Issue 10 | Volume 6
The Cover Story tracks how between 2015 and 2025, India’s healthcare and biotech firms transformed CSR from basic compliance to strategic, impact-driven initiatives. Also featuring interviews with: Merck Life Science’s Dhananjay Singh on strengthening India’s R&D and lab infrastructure. Maverick Simulation Solutions’ Anuj Chahal on investing Rs 50 crore in R&D, AI, and immersive learning.
India breaks into top 10 in Cytiva’s 2025 Global Biopharma Index
India climbs five places in global ranking, driven by growing R&D capacity and generics strength
Thermo Fisher Scientific expands Bengaluru R&D Hub with Rs 160 Crore...
The center will create 100+ jobs in Karnataka in the coming years





























































